This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

In a leap forward for genetic and biomedical research, two scientists at the University of Missouri have developed a powerful ...

Imagine cells navigating through a complex maze, guided by chemical signals and the physical landscape of their environment.

Excessive sequestration of KEAP1 into phase-separated p62 bodies under conditions of impaired autophagy drives persistent ...

Docling uses state-of-the-art models for layout analysis and table structure recognition to transform unstructured documents ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

The team takes a step forward ... May 15, 2025 — Researchers have developed a new stem cell model of the mature human amniotic sac, which replicates development of the tissues supporting the ...

Novel Gene Therapy is Addressing Both Type 1 and Type 2 Diabetes AUSTIN, Texas, May 28, 2025 /PRNewswire/ -- Genprex, Inc. (Genprex or th ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

Market Value and Growth In 2025, the Gene Therapy For Rare Disease Market Size is valued at approximately US$ 3.01 Billion in 2024, marking a substantial increase from previous years. This growth ...